BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• FDA

  Lannett Company, Inc. Receives FDA Approval for Hydrochlorothiazide Capsules, 12.5 mg

  January 30, 2012

   · 

  2 min read
• BioCapital

  MaxCyte, Inc. Announces Gram-Scale Antibody & Protein Production from the Transient Transfection of CHO Cells

  January 30, 2012

   · 

  1 min read
• FDA

  CardioKinetix Inc. Receives Expanded CE Mark Approval for World’s First Percutaneous Left Ventricular Partitioning Device, the Parachute(TM), for Treatment of Ischemic Heart Failure

  January 30, 2012

   · 

  3 min read
• Genetown

  T2 Biosystems Invited to Speak at Upcoming Medical Conferences

  January 30, 2012

   · 

  1 min read
• Business

  Alexion Pharmaceuticals Inc. to Report Fourth Quarter and Full Year 2011 Results on Thursday, February 9, 2012

  January 30, 2012

   · 

  1 min read
• Valeant Pharmaceuticals International to Syndicate Senior Secured Term Loan Credit Facility

  January 30, 2012

   · 

  2 min read
• Deals

  Valeant Pharmaceuticals International Withdraws Bid for ISTA Pharmaceuticals, Inc.

  January 30, 2012

   · 

  2 min read
• Deals

  Physio-Control Completes Sale to Bain Capital

  January 30, 2012

   · 

  1 min read
• Business

  ImmunoGen, Inc. Announces Addition of Kristine Peterson and Dean Mitchell to Its Board of Directors

  January 30, 2012

   · 

  1 min read
• Policy

  Advanced Biofuels, LLC’s Butamax™ Refutes Unfounded Allegations of Infringement

  January 30, 2012

   · 

  2 min read